| Literature DB >> 26671282 |
Noreen van der Linden1, Lieke J J Klinkenberg1, Marika Leenders2,3, Michael Tieland3,4, Lex B Verdijk2,3, Marijke Niens5, Jeroen D E van Suijlen5, Lisette C P G M de Groot3,4, Otto Bekers1, Luc J C van Loon2,3, Marja P van Dieijen-Visser1, Steven J R Meex1.
Abstract
With the introduction of high-sensitive assays, cardiac troponins became potential biomarkers for risk stratification and prognostic medicine. Observational studies have reported an inverse association between physical activity and basal cardiac troponin levels. However, causality has never been demonstrated. This study investigated whether basal cardiac troponin concentrations are receptive to lifestyle interventions such as exercise training. Basal high-sensitive cardiac troponin T (cTnT ) and I (cTnI) were monitored in two resistance-type exercise training programs (12-week (study 1) and 24-week (study 2)) in older adults (≥65 years). In addition, a retrospective analysis for high sensitive troponin I in a 24-week exercise controlled trial in (pre)frail older adults was performed (study 3). In total, 91 subjects were included in the final data analyses. There were no significant changes in cardiac troponin levels over time in study 1 and 2 (study 1: cTnT -0.13 (-0.33-+0.08) ng/L/12-weeks, cTnI -0.10 (-0.33-+0.12) ng/L/12-weeks; study 2: cTnT -1.99 (-4.79-+0.81) ng/L/24-weeks, cTnI -1.59 (-5.70-+2.51) ng/L/24-weeks). Neither was there a significant interaction between training and the course of cardiac troponin in study 3 (p = 0.27). In conclusion, this study provides no evidence that prolonged resistance-type exercise training can modulate basal cardiac troponin levels.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26671282 PMCID: PMC4680870 DOI: 10.1038/srep18320
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical Characteristics.
| Variable | Older men 12-w intervention (n = 13) | Older men and women 24-w intervention (n = 26) | (pre)Frail older men and women 24-w intervention (n = 25) | (pre)Frail older men and women control (n = 27) |
|---|---|---|---|---|
| Demographics | ||||
| Age (years), mean (SD) | 72.4 (5.4) | 69.2 (4.1) | 78.6 (6.8) | 80.2 (7.4) |
| Women, n (%) | 0 (0) | 12 (46) | 17 (68) | 14 (52) |
| BMI (kg/m2), mean (SD) | 27.4 (3.8) | 25.9 (2.0) | 28.7 (4.9) | 26.6 (3.3) |
| Medical history | ||||
| Systolic BP (mm Hg), mean (SD) | 147 (14) | 137 (15) | 142 (18) | 151 (24) |
| Diastolic BP (mm Hg), mean (SD) | 82 (17) | 77 (22) | 72 (9) | 75 (9) |
| Laboratory data | ||||
| Fasting glucose (mmol/L), mean (SD) | 5.6 (0.7) | 5.5 (0.5) | 5.3 (0.5) | 5.2 (0.5) |
| Total cholesterol (mmol/L), mean (SD) | 5.6 (1.1) | 6.2 (0.9) | 5.2 (1.5) | 5.4 (1.1) |
| Triglycerides (mmol/L), mean (SD) | 1.4 (0.5) | 1.3 (0.5) | 1.3 (0.5) | 1.2 (0.6) |
| HDL cholesterol (mmol/L), mean (SD) | 1.3 (0.4) | 1.6 (0.3) | 1.3 (0.3) | 1.5 (0.4) |
| LDL cholesterol (mmol/L), mean (SD) | 3.6 (1.3) | 4.3 (0.8) | 3.2 (1.3) | 3.4 (0.9) |
| Creatinine (μmol/L), mean (SD) | 102.2 (7.5) | 88.1 (17.4) | 74.4 (14.1) | 77.7 (12.1) |
| Cystatin C (mg/L), mean (SD) | 1.07 (0.11) | 0.90 (0.19) | 1.00 (0.29) | 1.08 (0.25) |
| eGFR (ml/min/1.73 m2), mean (SD)* | 66.3 (7.2) | 78.3 (15.2) | 73.9 (15.4) | 69.6 (13.9) |
| NT-proBNP (pg/mL), median (IQR) | 12.1 (6.8–21.0) | 7.6 (3.1–15.8) | 14.6 (6.2–25.3) | 19.1 (8.0–46.3) |
| Medication use | ||||
| Antihypertensives, n (%) | 3 (25) | 3 (12) | 11 (44) | 14 (52) |
| Statins, n (%) | 1 (8) | 1 (4) | 9 (36) | 3 (11) |
*eGFR, estimated glomerular filtration rate based on the the CKD-EPI creatinine-cystatin C equation (2012)29.
Figure 1Course of cardiac troponinT and I in older adults participating in 12- and 24-week training programs.
Median (interquartile range) concentrations of cTn in older adults participating in a supervised resistance-type training program: (A) course of cTnT in older men in a 12-week training program; (B) course of cTnI in older men in a 12-week training program; (C) course of cTnT in older men and women in a 24-week training program; (D) course of cTnI in older men and women in a 24-week training program.
Baseline and follow-up concentrationsof cTn in older adults participating in 12-week and 24-week training programs.
| hs-cTnT (ng/L) ), median (IQR) | hs-cTnI (ng/L) ), median (IQR) | |||
|---|---|---|---|---|
| 12-w intervention (n = 13) | 24-w intervention (n = 25) | 12-w intervention (n = 13) | 24-w intervention (n = 26) | |
| 9.1 (6.0–12.1) | 6.4 (5.0–8.7) | 5.1 (4.0–7.4) | 4.1 (3.2–5.2) | |
| 9.3 (5.8–10.7) | 7.4 (5.2–8.6) | 5.9 (3.2–9.8) | 3.9 (2.9–5.7) | |
| 9.6 (5.9–10.8) | 6.7 (5.6–9.4) | 5.1 (3.4–7.1) | 3.9 (3.3–5.1) | |
| 7.8 (4.4–8.8) | 6.5 (5.9–8.5) | 4.6 (2.7–6.3) | 4.0 (3.1–5.1) | |
| 6.6 (5.3–9.2) | 4.1 (3.1–5.2) | |||
| 5.9 (4.8–8.6) | 3.6 (2.9–4.8) | |||
| 6.1 (4.5–8.0) | 3.8 (2.9–4.8) | |||
Baseline and follow-up concentrations of hs-cTnI in (pre)frail older subjects in the control group and those participating in a 24-week resistance-type exercise training program.
| Variable | (pre)Frail older subjects 24-w intervention (n = 25) | (pre)Frail older subjects no intervention (n = 27) |
|---|---|---|
| Baseline hs-cTnI (ng/L), median (IQR) | 4.4 (3.3–6.2) | 6.7 (4.7–7.7) |
| 12-week hs-cTnI (ng/L), median (IQR) | 4.6 (3.5–6.4) | 6.7 (4.4–8.4) |
| 24-week hs-cTnI (ng/L), median (IQR) | 4.3 (3.6–8.4) | 6.0 (3.4–7.6) |